Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CTIC Insider Trading

CTIC | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at CTIC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2015-10-02 01:21 2015-09-29 SINGER JACK W Officer - EVP, Global Medical Affairs SELL $1.42 100,000 $141,790 1,351,850 -6.9%
2015-10-02 00:58 2015-09-29 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $1.41 170,000 $239,547 941,347 -15.3%
2015-10-02 02:13 2015-09-30 LOVE RICHARD L Director SELL $1.45 13,660 $19,852 530,449 -2.5%
2015-10-02 01:49 2015-09-29 BIANCO JAMES A Director, Officer - President and CEO SELL $1.43 600,000 $860,160 3,221,519 -15.7%
2015-10-02 02:26 2015-09-29 NUDELMAN PHILLIP M PHD Director SELL $1.45 150,000 $217,500 342,174 -30.5%
2015-09-25 23:42 2015-09-24 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.57 75,869 $119,038 725,084 -9.5%
2015-09-26 01:51 2015-09-25 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.64 15,000 $24,584 1,451,850 -1.0%
2015-09-26 02:00 2015-09-24 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $1.52 10,000 $15,200 1,111,347 -0.9%
2015-09-05 01:54 2015-09-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.54 10,000 $15,354 649,214 -1.5%
2015-08-29 01:41 2015-08-28 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.58 15,000 $23,718 1,260,919 -1.2%
2015-08-07 02:00 2015-08-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.84 10,000 $18,426 671,740 -1.5%
2015-07-25 01:29 2015-07-24 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.91 15,000 $28,664 1,275,919 -1.2%
2015-07-25 01:30 2015-07-23 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $1.91 10,000 $19,100 915,416 -1.1%
2015-07-09 00:54 2015-07-06 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.95 10,000 $19,493 681,740 -1.4%
2015-06-27 01:50 2015-06-26 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $2.07 15,000 $31,023 1,290,919 -1.1%
2015-06-27 01:22 2015-06-25 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.18 10,000 $21,800 925,416 -1.1%
2015-06-06 00:30 2015-06-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.06 10,000 $20,612 691,740 -1.4%
2015-05-23 00:00 2015-05-22 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.74 15,000 $26,045 1,305,919 -1.1%
2015-05-23 00:15 2015-05-21 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $1.80 10,000 $18,000 935,416 -1.1%
2015-05-05 01:34 2015-05-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.86 10,000 $18,552 701,740 -1.4%
2015-04-28 00:46 2015-04-24 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.96 15,000 $29,444 1,320,919 -1.1%
2015-04-25 00:15 2015-04-23 BIANCO LOUIS A Officer - EVP,Finance and Administration SELL $1.93 10,000 $19,300 945,416 -1.0%
2015-04-09 00:43 2015-04-06 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.88 16,569 $31,183 711,740 -2.3%
2015-03-25 01:56 2015-03-23 Plunkett Matthew Officer - EVP, Corporate Development SELL $1.96 59,130 $116,031 728,309 -7.5%
2015-03-25 00:23 2015-03-20 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $1.94 67,600 $131,124 1,429,889 -4.5%
2015-03-25 00:51 2015-03-23 BIANCO JAMES A Director, Officer - President and CEO SELL $1.95 175,199 $341,112 3,313,916 -5.0%
2015-03-21 00:56 2015-03-20 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $1.94 63,000 $122,012 1,022,152 -5.8%
2015-03-07 01:12 2015-03-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.41 12,000 $28,939 847,223 -1.4%
2015-02-28 01:07 2015-02-27 SINGER JACK W Director, Officer - EVP Global Medical Affairs SELL $2.35 15,000 $35,252 1,497,489 -1.0%
2015-02-07 02:42 2015-02-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.22 12,000 $26,651 859,223 -1.4%
2015-02-07 01:53 2015-02-05 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.22 10,000 $22,201 1,085,152 -0.9%
2015-01-10 03:10 2015-01-08 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.32 10,000 $23,206 617,897 -1.6%
2015-01-08 03:40 2015-01-05 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.36 12,000 $28,364 393,968 -3.0%
2014-12-20 02:39 2014-12-18 BIANCO JAMES A Director, Officer - President and CEO SELL $2.44 40,000 $97,552 1,910,726 -2.1%
2014-12-06 01:55 2014-12-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.23 12,000 $26,808 405,968 -2.9%
2014-12-06 02:44 2014-12-04 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.25 10,000 $22,530 627,897 -1.6%
2014-11-08 02:23 2014-11-06 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.37 10,000 $23,700 637,897 -1.5%
2014-11-07 04:01 2014-11-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.39 12,000 $28,664 417,968 -2.8%
2014-10-09 00:59 2014-10-06 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.39 12,000 $28,733 429,968 -2.7%
2014-09-25 01:46 2014-09-22 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.56 103,635 $264,922 441,968 -19.0%
2014-09-25 01:57 2014-09-22 BIANCO JAMES A Director, Officer - President and CEO SELL $2.53 307,068 $776,575 1,950,726 -13.6%
2014-09-20 02:18 2014-09-19 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.59 145,000 $375,898 647,897 -18.3%
2014-09-06 01:11 2014-09-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.48 27,301 $67,616 545,603 -4.8%
2014-08-16 02:38 2014-08-15 BIANCO JAMES A Director, Officer - President and CEO SELL $2.54 40,000 $101,720 2,257,794 -1.7%
2014-08-07 01:31 2014-08-04 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.48 12,000 $29,722 572,904 -2.1%
2014-07-12 01:11 2014-07-10 BIANCO LOUIS A Officer - EVP, Finance & Administration SELL $2.73 10,000 $27,300 792,897 -1.2%
2014-07-10 01:24 2014-07-07 Plunkett Matthew Officer - EVP, Corporate Development SELL $2.89 12,000 $34,698 584,904 -2.0%
2014-03-29 01:41 2014-03-28 GREGORIAN VARTAN Director SELL $3.41 82,000 $279,784 468,937 -14.9%
2014-03-27 01:25 2014-03-24 SINGER JACK W Director, Officer - EVP, Global Medical Affairs SELL $3.47 60,000 $208,314 1,035,234 -5.5%
2014-03-27 02:05 2014-03-25 NUDELMAN PHILLIP M PHD Director SELL $3.56 100,000 $356,130 448,619 -18.2%
SHOW ENTRIES

How to Interpret $CTIC Trades

Not every insider transaction in CTIC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CTIC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CTIC

Insider activity data for CTIC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CTIC, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.